| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.099 | 0.06 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.06 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |